This group also used the TCGA bladder cancer dataset to demonstrate that APOBEC mutagenesis is associated with improved overall survival, and that APOBEC-high tumors are enriched for TP53 and PIK3CA mutations [4]. This evidence concerns the gene TP53 and urinary bladder carcinoma.